Esperion Therapeutics, Inc. (ESPR) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -27.72M | 45.24M | -4.29M | -31.42M | -22.63M | -34.95M | -35.33M | -7.21M | 53.83M | -37.06M | -19.32M | -24.75M | -54.36M | -42.25M | -43.05M | -50.53M | -38.99M | -57.71M | -69.17M | -47.87M |
| Operating CF Margin % | -34.61% | 26.86% | -4.91% | -38.14% | -34.82% | -50.57% | -68.42% | -9.76% | 39.08% | -114.9% | -56.89% | -95.98% | -223.42% | -224.54% | -226.83% | -268.2% | -207% | -374.69% | -480.04% | -117.73% |
| Operating CF Growth % | -22.51% | 229.44% | 87.87% | -336.11% | -142.04% | 5.68% | -82.79% | 70.89% | 199.03% | 12.3% | 55.11% | 51.02% | -39.41% | 26.78% | 37.76% | -5.57% | 56.22% | 15.82% | 20.19% | -134.34% |
| Net Income | -25.2M | 61.83M | -31.33M | -12.72M | -40.45M | -21.32M | -29.52M | -61.92M | 61.02M | -56.34M | -41.25M | -49.94M | -61.72M | -55.49M | -55.12M | -66.32M | -56.73M | -65.12M | -69.39M | -43.67M |
| Depreciation & Amortization | 27K | 1.42M | 873K | 27K | 725K | 27K | -411K | 10K | 0 | 6K | 26K | 51K | 81K | 92K | 105K | 150K | 153K | 153K | 153K | 153K |
| Stock-Based Compensation | 0 | 2.39M | 2.35M | 2.67M | 2.46M | 2.81M | 3.02M | 2.93M | 3.23M | 2.92M | 2.98M | 3.16M | 2.9M | 0 | 0 | 3.53M | 4.44M | 4.47M | 5.5M | 8.58M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.5M | 926K | 14.13M | 4.92M | 2.61M | 4.84M | 4.01M | 56.78M | 11.37M | 12.41M | 12.35M | 11.81M | 11.4M | 15.36M | 14.99M | 11.81M | 11.59M | 8.37M | 10.86M | 8.34M |
| Working Capital Changes | -1.06M | -21.32M | 9.7M | -26.31M | 12.03M | -21.31M | -12.42M | -5M | -21.8M | 3.96M | 6.58M | 10.16M | -7.02M | -2.21M | -3.03M | 301K | 1.57M | -5.58M | -16.29M | -21.28M |
| Change in Receivables | 7.84M | -21.21M | -11.23M | -26.45M | -1.15M | -12.32M | -7.46M | -5.75M | -6.12M | -5.87M | -1.82M | -4.38M | -2.69M | -2.24M | -3.65M | -2.73M | -2.18M | -1.22M | 144K | 0 |
| Change in Inventory | 915K | 3.42M | 5.93M | -15.14M | -4.83M | -14.39M | 4.37M | -11.37M | -7.47M | -14.19M | -5.76M | -6.32M | -4.15M | -5.66M | -313K | 6.42M | -1.26M | -422K | -10.26M | -3.68M |
| Change in Payables | 3.34M | -12.45M | 0 | 2.62M | 27.84M | 9.3M | -12.77M | 19.35M | -3.45M | 5.5M | 1.66M | 7.49M | -5.97M | 4.47M | 5.77M | -14.03M | 9.39M | -3.27M | -8.65M | -599K |
| Cash from Investing | -189K | 189K | 0 | 0 | 0 | 0 | -167K | -77K | -73K | 0 | 0 | 17.5M | 25M | -11.79M | 33M | 5M | -18.1M | -50.48M | 0 | 0 |
| Capital Expenditures | -189K | 189K | 0 | 0 | 0 | 0 | -167K | -77K | -73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 0.24% | 0.11% | - | - | - | - | 0.32% | 0.1% | 0.05% | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 16.22M | 30.16M | 10.67M | 2.85M | -7.5M | 35M | -9.1M | -30.02M | 90.61M | 4.47M | -4.31M | 809K | 49.49M | -30.58M | 46.51M | 18.11M | -1.44M | 213.41M | 3.65M | 49.11M |
| Debt Issued (Net) | 0 | -54.91M | 0 | 0 | 0 | 35.01M | -9.63M | -39.09M | -5.83M | -4.6M | -4.29M | -3.51M | -3.11M | -52.56M | -2.36M | -2.1M | -1.22M | -1.44M | 0 | 48.9M |
| Equity Issued (Net) | 16.22M | 84.83M | 0 | 2.85M | 0 | -18K | 531K | 9.07M | 96.44M | 9.07M | -20K | 4.32M | 52.6M | 21.99M | 48.65M | 20.21M | 0 | 214.85M | 4.39M | 168K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 244K | 10.67M | 0 | -7.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 219K | 0 | -219K | 0 | -733K | 50K |
| Net Change in Cash | -11.69M | 75.41M | 6.39M | -28.57M | -30.13M | 44K | -44.59M | -37.3M | 144.36M | -32.59M | -23.64M | -6.44M | 20.14M | -34.62M | 36.46M | -27.42M | -58.53M | 105.22M | -65.51M | 1.25M |
| Free Cash Flow | -27.91M | 45.43M | -4.29M | -31.42M | -22.63M | -34.95M | -35.49M | -7.28M | 53.76M | -37.06M | -19.32M | -24.75M | -54.36M | -42.25M | -43.05M | -50.53M | -38.99M | -57.71M | -69.17M | -47.87M |
| FCF Margin % | -34.84% | 26.97% | -4.91% | -38.14% | -34.82% | -50.57% | -68.74% | -9.86% | 39.03% | -114.9% | -56.89% | -95.98% | -223.42% | -224.54% | -226.83% | -268.2% | -207% | -374.69% | -480.04% | -117.73% |
| FCF Growth % | -23.35% | 229.98% | 87.92% | -331.5% | -142.09% | 5.68% | -83.66% | 70.58% | 198.89% | 12.3% | 55.11% | 51.02% | -39.41% | 26.78% | 37.76% | -5.57% | 56.22% | 16.03% | 20.12% | -134.48% |
| FCF per Share | -0.11 | 0.16 | -0.02 | -0.16 | -0.12 | -0.18 | -0.18 | -0.04 | 0.28 | -0.33 | -0.17 | -0.23 | -0.69 | -0.57 | -0.63 | -0.80 | -0.64 | -1.57 | -2.61 | -1.83 |
| FCF Conversion (FCF/Net Income) | 1.10x | 0.73x | 0.14x | 2.47x | 0.56x | 1.64x | 1.20x | 0.12x | 0.88x | 0.66x | 0.47x | 0.50x | 0.88x | 0.76x | 0.78x | 0.76x | 0.69x | 0.89x | 1.00x | 1.10x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |